back to top
HomeTagsGuggenheim

Guggenheim

Tenax Therapeutics to Current on the Guggenheim Healthcare Innovation Convention By Investing.com

CHAPEL HILL, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Part 3, development-stage pharmaceutical firm centered on...

Most Popular

spot_img